Submission Details
| 510(k) Number | K200571 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 04, 2020 |
| Decision Date | May 01, 2020 |
| Days to Decision | 58 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
K200571 is an FDA 510(k) clearance for the PERLA? Posterior Occipito-Cervico-Thoracic Fixation System, a Posterior Cervical Screw System (Class II — Special Controls, product code NKG), submitted by Spineart (Plan Les Ouates, CH). The FDA issued a Cleared decision on May 1, 2020, 58 days after receiving the submission on March 4, 2020. This device falls under the Orthopedic review panel. Regulated under 21 CFR 888.3075.
| 510(k) Number | K200571 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 04, 2020 |
| Decision Date | May 01, 2020 |
| Days to Decision | 58 days |
| Submission Type | Traditional |
| Review Panel | Orthopedic (OR) |
| Summary | Summary PDF |
| Product Code | NKG — Posterior Cervical Screw System |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 888.3075 |
| Definition | Posterior Cervical Screw Systems Are Intended For Use In Fusion Procedures Of The Cervical Spine And/or Craniocervical Junction And/or Cervicothoracic Junction For: 1) Spinal Fractures And Dislocations; 2) Deformities; 3) Instabilities; 4) Failed Previous Fusions; 5) Tumors; 6) Inflammatory Disorders; 7) Spinal Degeneration, 8) Facet Degeneration With Instability; And 9) Reconstruction Following Decompression To Treat Radiculopathy And/or Myelopathy. These Systems Are Also Intended To Stabilize The Spine In The Absence Of Fusion For A Limited Time Period In Patients With Tumors Involving The Cervical Spine In Whom Life Expectancy Is Of Insufficient Duration To Permit Achievement Of Fusion. |